Why Big Tech’s AI Capex Is Now Outrunning Cash Flow

out-running-cash

Early this week, I was in Los Angeles at the All-In Summit along with about 4,000 others, including tech investors, money managers and entrepreneurs. The ticket wasn’t cheap, but it was well worth it.

I was in the room when Jensen Huang, in the middle of a panel, took a call from President Trump and put him on speaker so the whole audience could hear. “The robots will not be taking over,” the president told the NVIDIA chief. “The AI will not be taking over the rest of the world. The whole thing is a hoax.”

That was Monday. Over that same weekend, AI-linked stocks fell worldwide after leaders of the biggest AI labs warned about the risks of their own technology. Chip stocks dropped nearly 6% in a single session.

So, which is it? A hoax? Or an existential threat?

See more: The AI Capex Warning: Alphabet Sets a Tense Stage for Amazon, Microsoft, and Meta

The Warnings Are Coming from Inside the Building

Anthropic’s Dario Amodei, who’s written that AI could cure most major diseases within a decade, published an essay this week arguing that, in his words, we must pace the frontier. In a separate post, OpenAI’s chief scientist, Jakub Pachocki, wrote that this moment calls for extreme caution and that he doubts anyone is prepared for what’s coming. OpenAI then published a framework for disclosing when its own models misbehave, along with six recent examples.

One Anthropic researcher quit outright, walking away two months before his equity vested. As he put it, he no longer has anything to gain from the company’s valuation.